Tuberculosis and its future in the COVID-19 era: The Pulmonology series 2021
Open Access
- 10 March 2021
- journal article
- editorial
- Published by Taylor & Francis in Pulmonology
- Vol. 27 (2) , 94-96
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportEuropean Respiratory Journal, 2019
- Tuberculosis in the news: How do Portuguese media cover TBPulmonology, 2018
- Strengthening tuberculosis control to advance towards elimination: The 2018 Rev. Port. Pneumol. (RPP) TB SeriesPulmonology, 2018
- Non-tuberculous mycobacterial pulmonary infectionsPulmonology, 2018
- Managing latent tuberculosis infection and tuberculosis in childrenPulmonology, 2018
- New drugs and perspectives for new anti-tuberculosis regimens ☆Pulmonology, 2018
- Point of care diagnostics for tuberculosisPulmonology, 2018
- Migration, TB control and elimination: Whom to screen and treat ☆Pulmonology, 2018
- Tuberculosis, social determinants and co-morbidities (including HIV)Pulmonology, 2018
- Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyondPulmonology, 2018